Number of shares and voting rights
Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF – Autorité des Marchés Financiers)
Press release
Avignon, December 4
th
2014
28.11.2014
Total number of outstanding shares forming the capital
- 9,194,933 ordinary shares under ISIN FR0000054694 - 1,292 shares issued from stock-options under ISIN FR0000054694 |
9,196,225 |
Number of shares with double voting rights | 871,541 |
Total number of gross voting rights | 10,067,766 |
Number of shares without voting rights
- 9,014 bearer shares in the frame of the liquidity contract |
- 9,014 |
Total number of exercisable voting rights* | 10,058,752 |
* Real number of voting rights = total number of voting rights – number of shares without voting rights
If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com
-
Financial schedule
- Annual revenue
- Annual results3 February 2015
31 March 2015
-
Upcoming events
- SFAF analysts meeting (Paris) 2 April 2015
Naturex has been listed since October 1996 on Euronext in Paris. Segment B
Total number of shares comprising the share capital: 9.196.225 (November 2014)
ISIN FR0000054694 NATUREX is a component of the CACT. Enternext CAC PEA-PME 150. CAC Small & Mid. CAC Small. Gaïa Index. Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME). Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility. Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY. TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY |
About Naturex
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage. Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food. nutraceutical. pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs 1.600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe. Morocco. the United States. Brazil. Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
- Contacts
Carole Alexandre
Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr |
Thierry-Bertrand Lambert
Chief Financial Officer Tel.: +33 (0)4 90 23 96 89 t.b.lambert@naturex.com |
Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :
-
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-38139-cp-naturex_041214.pdf
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer